Sermorelin, a synthetic analog of growth hormone–releasing hormone (GHRH 1–29), has long attracted scientific interest due to ...
Stefan Bornstein, MD, PhD, professor, made it clear during a press conference at the 67th Congress of the German Society of Endocrinology (DGE) that there is more than one interaction between them.
Hormones control essential processes like growth, metabolism, mood, and reproduction, but when their balance is disrupted, it ...
Peptide hormones and bile acids shaping immune tolerance of the liver: implications and applications
The exceptional immune tolerance of the liver is, in part, mediated by entero-pancreatic endocrine factors that enter the portal vein at elevated levels. These endocrine factors signal via cAMP, ...
CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...
In some cases, HR-positive/HER2-negative breast cancers may over time become resistant to endocrine therapy. This can occur through mutations in the estrogen receptor ...
An analysis of 12-year results from the C9741 breast cancer trial confirmed the benefit of dose-dense versus conventional chemotherapy for patients with node-positive disease, but also showed ...
The intricate link between endocrine disorders and cancer development has drawn significant interest, revealing how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results